<p>Andres Finzi of the Centre Hospitalier de l'Université de Montréal in Canada will develop a system called "reverse fusion" in which viral-like particles that incorporate the HIV receptor CD4 and its co-receptors CCR5 and CXCR4 fuse specifically with HIV-infected cells to deliver toxic genes that kill the HIV-infected cells.</p>


Andres Finzi of the Centre Hospitalier de l'Université de Montréal in Canada will develop a system called "reverse fusion" in which viral-like particles that incorporate the HIV receptor CD4 and its co-receptors CCR5 and CXCR4 fuse specifically with HIV-infected cells to deliver toxic genes that kill the HIV-infected cells.